PubRank

Markus Niemann

Author PubWeight™ 25.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009 2.88
2 Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 2011 2.54
3 Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation 2009 2.07
4 Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging 2013 1.54
5 Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. Am J Cardiol 2011 1.53
6 The different faces of echocardiographic left ventricular hypertrophy: clues to the etiology. J Am Soc Echocardiogr 2010 1.45
7 Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease. Eur Heart J Cardiovasc Imaging 2012 1.08
8 Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J Am Soc Nephrol 2014 1.07
9 Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure. J Hypertens 2009 0.94
10 The Fabry cardiomyopathy: models for the cardiologist. Annu Rev Med 2011 0.92
11 Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene. Circ Cardiovasc Genet 2012 0.91
12 Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med 2010 0.90
13 Cardiomyopathy of Friedreich ataxia. J Neurochem 2013 0.90
14 Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J 2013 0.88
15 Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry. Genet Med 2013 0.87
16 A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium. Eur Heart J 2007 0.87
17 Heart valve involvement in Fabry cardiomyopathy. Ultrasound Med Biol 2008 0.86
18 Interdisciplinary approach towards female patients with Fabry disease. Eur J Clin Invest 2011 0.86
19 Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS One 2013 0.85
20 Methods for assessment of left ventricular systolic function in technically difficult patients with poor imaging quality. J Am Soc Echocardiogr 2012 0.83
21 Screening for Fabry disease using genetic testing. Eur J Heart Fail 2010 0.80
22 Potential role of vitamin D deficiency on Fabry cardiomyopathy. J Inherit Metab Dis 2013 0.75
23 Failure to unmask pseudonormal diastolic function by a valsalva maneuver: tricuspid insufficiency is a major factor. Circ Cardiovasc Imaging 2011 0.75
24 [Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge]. Med Klin (Munich) 2010 0.75
25 Using simple imaging markers to predict prognosis in patients with aortic valve stenosis and unacceptable high risk for operation. Am J Cardiol 2013 0.75